Predictors of response and course in patients with inflammatory bowel disease treated with biological therapy: The Danish IBD-Biobank project

被引:0
|
作者
Zhao, M. [1 ]
Bendtsen, F. [1 ]
Petersen, A. M. [1 ,2 ]
Larsen, L. [3 ]
Jess, T. [3 ,4 ]
Dige, A. [5 ]
Hvas, C. [5 ]
Seidelin, J. [6 ]
Burisch, J. [1 ]
机构
[1] Hvidovre Univ Hosp, Gastro Unit, Div Med, Hvidovre, Denmark
[2] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark
[3] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] State Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark
[5] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark
[6] Herlev Univ Hosp, Gastro Unit, Med Div, Herlev, Denmark
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P634
引用
收藏
页码:S526 / S527
页数:2
相关论文
共 50 条
  • [31] The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease
    Reghefaoui, Maiss
    Peresuodei, Tariladei S.
    Palacios, Michell S. Saavedra
    Gill, Abhishek
    Orji, Chijioke
    Reghefaoui, Tiba
    Mostafa, Jihan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [32] Predictors of pancreatitis among patients with inflammatory bowel disease (IBD) treated with vedolizumab (VDZ): Observation from a large global safety database
    Wernicke, J.
    Verstak, T.
    Zhang, T.
    Spalding, W.
    Lee, L.
    Cheng, Y.
    Ademi, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I548 - I549
  • [33] Predictors of pancreatitis among patients with inflammatory bowel disease (IBD) treated with vedolizumab (VDZ): Observation from a large global safety database
    Wernicke, J.
    Verstak, T.
    Zhang, T.
    Spalding, W.
    Lee, L.
    Cheng, Y.
    Ademi, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I548 - I549
  • [34] DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY?
    De Blasio, F.
    Montori, M.
    Martini, F.
    Paolucci, L.
    Vitalini, T.
    Pieroni, G.
    Quatraccioni, C.
    Benedetti, A.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S138 - S138
  • [35] Determination of thiopurine methyltransferase (TPMT) activity in patients with inflammatory bowel disease (IBD) treated with azathioprine
    Sans, M
    Bufadel, ME
    Cara, C
    Penalva, M
    Pique, JM
    Panés, J
    GASTROENTEROLOGY, 2002, 122 (04) : A221 - A222
  • [36] Steroid use in inflammatory bowel disease patients on biological therapy in Montenegro
    Smolovic, B.
    Lukic, M.
    Sekulic, O.
    Muhovic, D.
    Milosevic, V.
    Vukcevic, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S419 - S420
  • [37] Allergic and paradoxical Disease Reactions under modern Biological Therapy for inflammatory System and Bowel Diseases (IBD)
    Raithel, Martin
    Sander, Oliver
    Wilsmann-Theis, Dagmar
    Kremenevskiy, Igor
    Moessner, Rotraut
    INTERNIST, 2020, 61 (SUPPL 1): : S30 - S30
  • [38] Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib
    Odah, Tarek
    Karime, Christian
    Desai, Aakash
    Picco, Michael F.
    Kinnucan, Jami A.
    Hashash, Jana G.
    Farraye, Francis A.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (10) : 3911 - 3919
  • [39] Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines
    Dotan, Iris
    Werner, Lael
    Vigodman, Sharon
    Agarwal, Shradha
    Pfeffer, Jorge
    Horowitz, Noya
    Malter, Lisa
    Abreu, Maria
    Ullman, Thomas
    Guzner-Gur, Hanan
    Halpern, Zamir
    Mayer, Lloyd
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (02) : 261 - 268
  • [40] Administration and monitoring of biologic therapy in patients with inflammatory bowel disease: A national Danish survey
    Volmar, S.
    Wildt, S.
    Munck, L. K.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S451 - S452